Filing Flows › Actinium Pharmaceuticals (ATNM) › How it makes money
How Actinium Pharmaceuticals (ATNM) makes money
Actinium Pharmaceuticals (ATNM) made $35.0M of revenue in the second quarter 2026 (Q2 2026). Of every dollar of revenue, 79¢ was left as operating profit, 80¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $35.0M | 100.0% |
| Operating profit | $27.6M | 78.8% |
| Net earnings | $27.9M | 79.7% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $35.0M | — |
| Q3 2025 | $90K | — |
From Actinium Pharmaceuticals' 10-Q filed Aug 7, 2026 (on EDGAR).
Questions
How does Actinium Pharmaceuticals make money?
Actinium Pharmaceuticals (ATNM) made $35.0M of revenue in the second quarter 2026 (Q2 2026). Of every dollar of revenue, 79¢ was left as operating profit, 80¢ was left as net earnings.
What is Actinium Pharmaceuticals' profit margin?
Net earnings were $27.9M, 79.7% of revenue, in the second quarter 2026; the operating margin was 78.8%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.